\-\ Texto\\:\\ \ \(0\)\
\-\ unremarkable\ \(371\)\
\-\ mr\\ study\\ vs\\.\\ sulfur\\ colloid\\ study\ \(0\)\
\-\ unenhanced\\ liver\\ ct\\ demonstrates\\ a\\ round\\ lesion\\ in\\ left\\ lobe\\ of\\ liver\\ that\\ is\\ isodense\\ to\\ liver\\ with\\ a\\ central\\ area\\ f\\ decreased\\ attenuation\\.\\ late\\ arterial\\ phase\\ image\\ demonstrates\\ enhancement\\ of\\ the\\ 4\\ cm\\ round\\ lesion\\ with\\ a\\ persistent\\ central\\ 1\\ cm\\ area\\ that\\ did\\ not\\ enhance\\.\\ portal\\ venous\\ phase\\ image\\ demonstrates\\ isoattenuation\\ to\\ liver\\ and\\ persistent\\ hypoattenuation\\ of\\ the\\ central\\ area\\.\ \(0\)\
\-\ this\\ is\\ a\\ differential\\ case\\.\\ final\\ diagnosis\\ is\\ pending\ \(0\)\
\-\ focal\\ nodular\\ hyperplasia\\ \\(most\\ likely\\ based\\ on\\ age\\,\\ gender\\ and\\ appearance\\)\ \(0\)\
\-\ hepatic\\ adenoma\ \(5\)\
\-\ fibrolamellar\\ hepatocellular\\ carcinoma\ \(0\)\
\-\ hemangioma\\ \\(less\\ likely\\)\ \(0\)\
\-\ 31\\ y\\.o\\.\\ female\\,\\ asymptomatic\\ had\\ incidental\\ finding\\ of\\ a\\ \\"hepatic\\"\\ lesion\\ in\\ a\\ ct\\ study\\ performed\\ in\\ korea\\.\\ patient\\ does\\ not\\ have\\ previous\\ study\\ and\\ a\\ repeat\\ ct\\ was\\ requested\\ at\\ a\\ dod\\ medical\\ facility\\.\\ patient\\ is\\ otherwise\\ in\\ good\\ health\\.\ \(0\)\
\-\ this\\ patient\\ was\\ lost\\ to\\ follow\\-up\\ and\\ will\\ remain\\ a\\ differential\\ case\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ liver\\:\\ 0\\.07014813121030294\ \(0\)\
\-\ study\\:\\ 0\\.06694360373476092\ \(0\)\
\-\ korea\\:\\ 0\\.05247332395218154\ \(0\)\
\-\ central\\:\\ 0\\.050207702801070696\ \(0\)\
\-\ isoattenuation\\:\\ 0\\.04834744787741996\ \(0\)\
\-\ dod\\:\\ 0\\.04834744787741996\ \(0\)\
\-\ area\\:\\ 0\\.04824707578811191\ \(0\)\
\-\ phase\\:\\ 0\\.04785390331392567\ \(0\)\
\-\ round\\:\\ 0\\.04394707672099094\ \(0\)\
\-\ hepatic\\:\\ 0\\.04248207561673824\ \(0\)\
\-\ persistent\\:\\ 0\\.040575555386980704\ \(0\)\
\-\ hypoattenuation\\:\\ 0\\.038767460303407456\ \(0\)\
\-\ sulfur\\:\\ 0\\.03720576825300572\ \(0\)\
\-\ fibrolamellar\\:\\ 0\\.036764649371138325\ \(0\)\
\-\ gender\\:\\ 0\\.03407426172981061\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0333325214580926\ \(0\)\
\-\ differential\\:\\ 0\\.032297140825630115\ \(0\)\
\-\ isodense\\:\\ 0\\.03222810144228775\ \(0\)\
\-\ image\\:\\ 0\\.03177606150354287\ \(0\)\
\-\ unenhanced\\:\\ 0\\.0313105378718874\ \(0\)\
\-\ lesion\\:\\ 0\\.031081343321436687\ \(0\)\
\-\ colloid\\:\\ 0\\.029948385655049026\ \(0\)\
\-\ requested\\:\\ 0\\.029683791830222638\ \(0\)\
\-\ lost\\:\\ 0\\.029683791830222638\ \(0\)\
\-\ hepatocellular\\:\\ 0\\.02930772693961828\ \(0\)\
\-\ likely\\:\\ 0\\.028693928165900672\ \(0\)\
\-\ remain\\:\\ 0\\.02851289722161517\ \(0\)\
\-\ health\\:\\ 0\\.028202267738457014\ \(0\)\
\-\ facility\\:\\ 0\\.027811807723660507\ \(0\)\
\-\ final\\:\\ 0\\.027445391693901977\ \(0\)\
\-\ cm\\:\\ 0\\.02728519187877364\ \(0\)\
\-\ portal\\:\\ 0\\.026773989943036834\ \(0\)\
\-\ 31\\:\\ 0\\.026695149307620042\ \(0\)\
\-\ f\\:\\ 0\\.026540533317124443\ \(0\)\
\-\ late\\:\\ 0\\.02646470578273498\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.02506159665463337\ \(0\)\
\-\ enhance\\:\\ 0\\.024603495219299276\ \(0\)\
\-\ repeat\\:\\ 0\\.023926951656962837\ \(0\)\
\-\ hemangioma\\:\\ 0\\.022728012798823707\ \(0\)\
\-\ arterial\\:\\ 0\\.022263956004361138\ \(0\)\
\-\ case\\:\\ 0\\.022256005153181792\ \(0\)\
\-\ pending\\:\\ 0\\.02200907506874847\ \(0\)\
\-\ good\\:\\ 0\\.02176466145685696\ \(0\)\
\-\ ct\\:\\ 0\\.02134470809628648\ \(0\)\
\-\ nodular\\:\\ 0\\.021335772661380425\ \(0\)\
\-\ a\\:\\ 0\\.021246417954567925\ \(0\)\
\-\ adenoma\\:\\ 0\\.02124103780836912\ \(0\)\
\-\ attenuation\\:\\ 0\\.02045012541920261\ \(0\)\
\-\ vs\\:\\ 0\\.02002666649048094\ \(0\)\
\-\ previous\\:\\ 0\\.019752084515912476\ \(0\)\
\-\ based\\:\\ 0\\.01939696644206524\ \(0\)\
\-\ incidental\\:\\ 0\\.01926064641654926\ \(0\)\
\-\ venous\\:\\ 0\\.018463009633673387\ \(0\)\
\-\ did\\:\\ 0\\.018365587148767404\ \(0\)\
\-\ otherwise\\:\\ 0\\.018269733532299673\ \(0\)\
\-\ that\\:\\ 0\\.0175711991495098\ \(0\)\
\-\ does\\:\\ 0\\.017354887323714322\ \(0\)\
\-\ less\\:\\ 0\\.017225833359063584\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.01719400236902433\ \(0\)\
\-\ unremarkable\\:\\ 0\\.016839681063583693\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.016547839234772273\ \(0\)\
\-\ finding\\:\\ 0\\.016393223244276674\ \(0\)\
\-\ mr\\:\\ 0\\.016161901618728772\ \(0\)\
\-\ will\\:\\ 0\\.015913577490352035\ \(0\)\
\-\ medical\\:\\ 0\\.015650653571821452\ \(0\)\
\-\ age\\:\\ 0\\.015481609080620871\ \(0\)\
\-\ patient\\:\\ 0\\.015296284480649784\ \(0\)\
\-\ decreased\\:\\ 0\\.015123550016217615\ \(0\)\
\-\ not\\:\\ 0\\.014700222282642087\ \(0\)\
\-\ y\\.o\\:\\ 0\\.014680829955873213\ \(0\)\
\-\ appearance\\:\\ 0\\.014547062956753818\ \(0\)\
\-\ focal\\:\\ 0\\.014526747643680964\ \(0\)\
\-\ carcinoma\\:\\ 0\\.014416236131046823\ \(0\)\
\-\ performed\\:\\ 0\\.014182013876353088\ \(0\)\
\-\ 4\\:\\ 0\\.014172451816541936\ \(0\)\
\-\ lobe\\:\\ 0\\.013686460404306749\ \(0\)\
\-\ enhancement\\:\\ 0\\.01363386170311331\ \(0\)\
\-\ is\\:\\ 0\\.0133878756758268\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.012500803795427482\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.012260413702275255\ \(0\)\
\-\ 1\\:\\ 0\\.012103133142617302\ \(0\)\
\-\ was\\:\\ 0\\.011765208597781985\ \(0\)\
\-\ most\\:\\ 0\\.011743066319809975\ \(0\)\
\-\ diagnosis\\:\\ 0\\.01167987696893107\ \(0\)\
\-\ this\\:\\ 0\\.011442109682311108\ \(0\)\
\-\ have\\:\\ 0\\.011014512371220784\ \(0\)\
\-\ had\\:\\ 0\\.010975296543099453\ \(0\)\
\-\ female\\:\\ 0\\.010456906377665677\ \(0\)\
\-\ in\\:\\ 0\\.010033267384291783\ \(0\)\
\-\ \\(\\:\\ 0\\.008599544360045959\ \(0\)\
\-\ \\)\\:\\ 0\\.008494496334682203\ \(0\)\
\-\ to\\:\\ 0\\.007626216222196183\ \(0\)\
\-\ at\\:\\ 0\\.006891447338283529\ \(0\)\
\-\ left\\:\\ 0\\.005691102793291158\ \(0\)\
\-\ on\\:\\ 0\\.004308875073603738\ \(0\)\
\-\ and\\:\\ 0\\.004285928707909963\ \(0\)\
\-\ \\,\\:\\ 0\\.003222738875205802\ \(0\)\
\-\ of\\:\\ 0\\.0027739000189997243\ \(0\)\
\-\ \\.\\:\\ 0\\.0021130676248420402\ \(0\)\
\-\ the\\:\\ 0\\.001645824817900307\ \(0\)\
\-\ with\\:\\ 0\\.0013929068582129729\ \(0\)\
